Male gender is an adverse prognostic factor in B-cell lymphoma patients treated with immunochemotherapy.
Riihijärvi
Sari
S
Department of Oncology, Helsinki University Central Hospital, Helsinki Genome-Scale Biology Research Program, Biomedicum Helsinki, University of Helsinki, Helsinki, Finland.
Taskinen
Minna
M
Jerkeman
Mats
M
Leppä
Sirpa
S